
A fast-growing global pharmaceutical company developing, manufacturing and distributing generic, biosimilar and added-value medicines in over 85 countries, helping improve patient access to essential pharmaceutical care. Accord's portfolio spans therapeutic areas including oncology, cardiology, neurology, psychiatry, diabetes, pain management and gastroenterology, with a focus on delivering high-quality medicines faster, more economically and reliably.

Keine Kommentare verfügbar.
Bewertung & Kommentar hinterlassen